Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
7 Results for "
human LOXL2
" in MedChemExpress (MCE) Product Catalog:
Products (7)
7 Results for "human LOXL2" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-114286A
Purity: 99.67%
Target:
Research Areas:
PXS-5153A monohydrochloride is a potent, selective, orally active and fast-acting lysyl oxidase like 2/3 enzymatic (LOXL2/LOXL3) inhibitor, with an IC50 of <40 nM for LOXL2 across all mammalian species and an IC50 of 63 nM for human LOXL3. PXS-5153A monohydrochloride could reduce crosslinks and ameliorates fibrosis.
Cat. No.: HY-114286
CAS No.: 2125956-82-1
Target:
Research Areas:
PXS-5153A is a potent, selective, orally active and fast-acting lysyl oxidase like 2/3 enzymatic (LOXL2/LOXL3) inhibitor, with an IC50 of <40 nM for LOXL2 across all mammalian species and an IC50 of 63 nM for human LOXL3. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
Target:
Research Areas:
PXS-4787 hydrochloride is a specific and effective pan-LOX (lysyl oxidase) inhibitor for abolishing lysyl oxidase activity. PXS-4787 hydrochloride inhibits LOX with IC50s of 2 μM (Bovine LOX), 3.2 μM (rh LOXL1), 0.6 μM (rh LOXL2), 1.4 μM (rh LOXL3), 0.2 μM (rh LOXL4), respectively. PXS-4787 hydrochloride reduces deposition and crosslinking of collagen I secreted by human fibroblasts .
Cat. No.: HY-RS07742
Target:
Research Areas:
LOXL2 Human Pre-designed siRNA Set A contains three designed siRNAs for LOXL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-183644
Target:
Research Areas:
LNO 9 is an orally active LOXL2 inhibitor and NO donor, with an IC50 of 0.17 μM against human LOXL2. LNO 9 competitively binds to the LTQ cofactor of LOXL2 to form an irreversible complex, thereby inhibiting collagen oxidation and abnormal cross-linking. LNO 9 releases nitric oxide (NO) to increase cGMP levels in pulmonary artery smooth muscle cells. LNO 9 inhibits hypoxia-induced collagen modification and possesses vasodilatory activity. LNO 9 ameliorates right ventricular hypertrophy and pulmonary artery medial thickness in rat models induced by hypoxia and Monocrotaline (HY-N0750), and can be used for research on pulmonary hypertension .
Cat. No.: HY-P74771
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LOXL2; Lysyl Oxidase-Related Protein 2; Lysyl Oxidase Like 2; Lysyl Oxidase-Like 2 Delta E13; Lysyl Oxidase-Like Protein 2; Lysyl Oxidase-Like 2 Protein; Lysyl Oxidase Homolog 2; Lysyl Oxidase Related 2; WS9-14; Lysyl Oxidase Homolog; LOR; Lysyl Oxidase-L
Species:
Human
Source:
CHO
Cat. No.: HY-P74770Y
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LOXL2; Lysyl Oxidase-Related Protein 2; Lysyl Oxidase Like 2; Lysyl Oxidase-Like 2 Delta E13; Lysyl Oxidase-Like Protein 2; Lysyl Oxidase-Like 2 Protein; Lysyl Oxidase Homolog 2; Lysyl Oxidase Related 2; WS9-14; Lysyl Oxidase Homolog; LOR; Lysyl Oxidase-L
Species:
Human
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
